Charles river announces extension of gene therapy manufacturing alliance with nus yong loo lin school of medicine

Wilmington, mass.--(business wire)--charles river laboratories international, inc. (nyse: crl) and national university of singapore's (nus) yong loo lin school of medicine (nus medicine), a leading medical education institution with a world-renowned medical research field of stem cell biology and therapy, today announced a high quality (hq) plasmid dna development and manufacturing agreement. nus medicine will utilize charles river's market leading contract development and manufacturing organiz.
CRL Ratings Summary
CRL Quant Ranking